Literature DB >> 21398124

Discovery of non-glucoside SGLT2 inhibitors.

An-Rong Li1, Jian Zhang, Joanne Greenberg, TaeWeon Lee, Jiwen Liu.   

Abstract

A series of benzothiazinone and benzooxazinone derivatives were discovered as SGLT2 inhibitors. The optimization led to the discovery of compounds 31 and 32, which exhibited similar potency and better SGLT1 selectivity compared to dapagliflozin. These compounds may provide novel promising scaffolds, which are different from phlorizin-based SGLT2 inhibitors.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398124     DOI: 10.1016/j.bmcl.2011.02.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 2.  Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-09

Review 3.  Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport.

Authors:  M A Abdul-Ghani; R A DeFronzo
Journal:  J Intern Med       Date:  2014-10       Impact factor: 8.989

Review 4.  SGLT inhibitors as antidiabetic agents: a comprehensive review.

Authors:  Rahul P Kshirsagar; Abhishek A Kulkarni; Rashmi S Chouthe; Shahebaaz K Pathan; Hemant D Une; G Bhanuprakash Reddy; Prakash V Diwan; Siddique Akber Ansari; Jaiprakash N Sangshetti
Journal:  RSC Adv       Date:  2020-01-09       Impact factor: 4.036

5.  Synthesis and biological evaluation of benzothiazin-4-ones: a possible new class of acetylcholinesterase inhibitors.

Authors:  Gabriele A Berwaldt; Daniela P Gouvêa; Daniel S da Silva; Adriana M das Neves; Mayara S P Soares; Juliana H Azambuja; Geonir M Siqueira; Roselia M Spanevello; Wilson Cunico
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.